← Back to Clinical Trials
Recruiting NCT05463991

Bioengineered Collagen Implant for Urethral Stricture Repair

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Urethral Stricture
Sponsor Regenosca SA
Study Type INTERVENTIONAL
Phase N/A
Enrollment 5
Sex MALE
Min Age 18 Years
Max Age N/A
Start Date 2022-08-15
Completion 2025-09
Interventions
Bioengineered collagen implant

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The field of research for this study is tissue engineering and the utilization of a bioengineered collagen implant as a substitute biomaterial for conventional buccal mucosa in substitution urethroplasty of distal urethral strictures.

Eligibility Criteria

Inclusion Criteria: Adult males with urethral stricture less than 3 cm (anywhere from penile to bulbar urethra not including the membranous urethra) with existing lumen of at least 6 Fr suitable for augmentation urethroplasty. The stricture may be due to trauma or infection. Exclusion Criteria: * Known bovine collagen allergy * Current urinary tract infection * Chronic renal failure * Diabeted * Neurological diseases * Chronic obstructive pulmonary diseases * Sleep disturbances * Depression * Former cancer treatment * Smokers * Recurrent stricture

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE URETHRAL STRICTURE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}